We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
-1.55%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+386.48%
AUM
$41.7B
AUM Growth
+$2.19B
Cap. Flow
+$590M
Cap. Flow %
1.42%
Top 10 Hldgs %
9.51%
Holding
3,328
New
131
Increased
1,345
Reduced
1,491
Closed
336
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HEOP
3301
DELISTED
Heritage Oaks Bancorp
HEOP
-15,247
Closed -$117K
QUNR
3302
DELISTED
Qunar Cayman Islands Limited
QUNR
-8,697
Closed -$248K
DSCI
3303
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
-11,145
Closed -$129K
YZC
3304
DELISTED
Yanzhou Coal Mining
YZC
-35,342
Closed -$265K
NWBO
3305
DELISTED
Northwest Biotherapeutics, Inc. Common stock
NWBO
-18,877
Closed -$126K
HTCH
3306
DELISTED
HUTCHINSON TECHNOLOGY INC
HTCH
-11,552
Closed -$29K
MGN
3307
DELISTED
MINES MGMT INC
MGN
-18,000
Closed -$20K
KKD
3308
DELISTED
KRISPY KREME DOUGHNUTS INC
KKD
-11,806
Closed -$188K
RKUS
3309
DELISTED
RUCKUS WIRELESS INC COM STK (DE)
RKUS
-54,254
Closed -$649K
PRMW
3310
DELISTED
Primo Water Corporation
PRMW
-10,825
Closed -$52K
CZR
3311
DELISTED
Caesars Entertainment Corporation
CZR
-13,003
Closed -$235K
RPRX
3312
DELISTED
Repros Therapeutics Inc.
RPRX
-11,953
Closed -$206K
ETRM
3313
DELISTED
EnteroMedics Inc.
ETRM
-17
Closed -$29K
GNVC
3314
DELISTED
GenVec, Inc.
GNVC
-1,027
Closed -$26K
CERE
3315
DELISTED
CERES, INC. COMMON STOCK NEW
CERE
-2,157
Closed -$11K
GRX.RT
3316
DELISTED
GABELLI HEALTHCARE & WELLNESS RT EXP 07/08/2014
GRX.RT
-27,720
Closed -$11K
AAN.A
3317
PUT
DELISTED
The Aaron's Company Inc Class A
AAN.A
-20,600
Closed -$735K
CNOB
3318
DELISTED
CONNECTONE BANCORP INC
CNOB
-17,330
Closed -$865K

Similar funds

Guggenheim Capital's Q3 2014 Portfolio in Review

As of Q3 2014, Guggenheim Capital held 3,328 positions worth $41.7B, up 5.5% from $39.5B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.

Guggenheim Capital's Q3 2014 filing shows 131 new, 1,345 increased, 1,491 reduced and 336 closed positions. Its largest new stake was Discovery, Inc. Series C Common Stock: 470,475 shares worth $17.5M. The largest sale was GUGGENGEIM BULLETSHARES 2015 HIGH YIELD CORPORATE BOND ETF, an estimated $98.4M.

By sector, the portfolio is most concentrated in Financials at 10% of assets, down from 11% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Guggenheim Capital's largest Q3 2014 buy was Discovery, Inc. Series C Common Stock: 470,475 shares worth $17.5M.
  • Guggenheim Capital added most to CLAYMORE GUGGENHEIM BULLETSHARES 2015 CORP BD ETF in Q3 2014, an estimated $96.3M increase.
  • Guggenheim Capital's biggest Q3 2014 reduction was GUGGENGEIM BULLETSHARES 2015 HIGH YIELD CORPORATE BOND ETF, cutting an estimated $98.4M.
  • Guggenheim Capital fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $40.1M.
  • Guggenheim Capital's ten largest holdings make up 9.5% of its $41.7B portfolio in Q3 2014.
  • Guggenheim Capital opened 131 new positions and closed 336 in Q3 2014.
  • Guggenheim Capital's portfolio value rose 5.5% quarter-over-quarter to $41.7B.

Based on Guggenheim Capital's 13F filing for Q3 2014, filed 14 Nov 2014.